Evonik shares rise on plans to divest two units as part of restructuring
German chemicals group Evonik's shares rose 3% after announcing plans to divest two units, Syneqt and Oxeno, as part of a reorganization strategy that will enter its second phase in 2027. The divestments, particularly the potential sale of C4-chemicals maker Oxeno, are seen as a key factor in the share price movement.